MENU
+Compare
PRPH
Stock ticker: NASDAQ
AS OF
Dec 23, 10:37 AM (EDT)
Price
$0.63
Change
+$0.02 (+3.28%)
Capitalization
116.75M

PRPH ProPhase Labs Forecast, Technical & Fundamental Analysis

a manufacturer of cold remedy products and other supplements

PRPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PRPH with price predictions
Dec 20, 2024

PRPH's Indicator enters downward trend

The Aroon Indicator for PRPH entered a downward trend on December 17, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 201 similar instances where the Aroon Indicator formed such a pattern. In of the 201 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PRPH as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for PRPH just turned positive on November 26, 2024. Looking at past instances where PRPH's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRPH advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

PRPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.496) is normal, around the industry mean (23.300). P/E Ratio (17.007) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.648) is also within normal values, averaging (43.338).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
PRPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PRPH is expected to report earnings to fall 31.43% to -23 cents per share on March 26

ProPhase Labs PRPH Stock Earnings Reports
Q4'24
Est.
$-0.24
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.25
Q1'24
Beat
by $0.21
Q4'23
Missed
by $0.25
The last earnings report on November 13 showed earnings per share of -34 cents, missing the estimate of -31 cents. With 4.92K shares outstanding, the current market capitalization sits at 116.75M.
A.I.Advisor
published Dividends

PRPH paid dividends on June 03, 2022

ProPhase Labs PRPH Stock Dividends
А quarterly dividend of $0.30 per share was paid with a record date of June 03, 2022, and an ex-dividend date of May 24, 2022. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of cold remedy products and other supplements

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
711 Stewart Avenue
Phone
+1 215 345-0919
Employees
129
Web
https://www.prophaselabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRPHF17.800.57
+3.34%
Galaxy Digital Holdings Ltd.
NDEKY16.400.11
+0.68%
Nitto Denko Corp.
NTIOF91.840.35
+0.38%
National Bank of Canada
ESLOY120.15-0.14
-0.12%
EssilorLuxottica
BSENF0.06-0.01
-9.52%
BASELODE ENERGY CORP.

PRPH and Stocks

Correlation & Price change

A.I.dvisor tells us that PRPH and FLGT have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and FLGT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
-6.52%
FLGT - PRPH
31%
Poorly correlated
-2.19%
RXST - PRPH
29%
Poorly correlated
-11.86%
ANIP - PRPH
28%
Poorly correlated
-1.68%
LFCR - PRPH
21%
Poorly correlated
+2.40%
ATRC - PRPH
21%
Poorly correlated
+2.23%
More